Rheumatoid Arthritis and Post-Covid Syndrome
MVZ „Meducus Wesken“, Am Wall Seud 20, 49890 Lingen, Germany.
Review
International Journal of Scholarly Research and Reviews, 2023, 02(02), 005–008.
Article DOI: 10.56781/ijsrr.2023.2.2.0022
Publication history:
Received on 18 February 2023; revised on 05 April 2023; accepted on 07 April 2023
Abstract:
As the SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) pandemic enters its third year, physicians are increasingly confronted with a new pathology, Post-COVID Syndrome (PCS). One of the common manifestations of PCS is a musculoskeletal symptom complex, manifested by myalgia, arthralgia, and arthritis. Today, there is no universally accepted term, definition, classification, diagnostic criteria, or consensus on the duration of PCS. In the literature there are enough descriptions of cases of the occurrence of rheumatoid arthritis (RA) after SARS-CoV-2. The question arises: is this a coincidence or could COVID-19 (coronavirus disease 2019) be a trigger factor for RA? From the perspective already expressed in medical circles, COVID-19 can unmask previously undiagnosed RA or cause disease de novo. In addition, the onset of arthritis can be a manifestation of PCS and can be transient. The trigger role of a SARS-CoV-2 infection in the occurrence of RA seems likely. The emergence of arthritis in the post-COVID period may pose problems in the differential diagnosis of joint damage.
Keywords:
SARS-CoV-2; COVID-19; Post-COVID syndrome; Rheumatoid arthritis
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0